Figure 2.

Examples of eligible patients presenting with ST-segment elevation.

Patient 1 presented with fever, a cough and typical ischemic chest pain with inferoposterior STEMI and, while full precautions were taken with PPE, had primary percutaneous coronary intervention (PCI) and subsequently tested negative for COVID-19. Patient 2 was a confirmed COVID-19 who developed diffuse ST-segment elevation in the critical care unit thought to be secondary to myocarditis and was treated with medical therapy. Patient 3 was a confirmed COVID-19 patient presenting with anterior myocardial infarction and had pharmacoinvasive therapy.

All 3 patients are eligible for the North American COVID-19 ST-Segment Elevation Myocardial Infarction (NACMI) registry.